MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 Genetic Test
Welcome to DNA Labs UAE, where we offer the MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 Genetic Test. This test is used to diagnose a rare neurodegenerative disorder called ceroid lipofuscinosis neuronal type 7 (CLN7).
Test Details
The MFSD8 gene is associated with CLN7, a disorder characterized by the accumulation of lipopigments in various tissues, including the brain. Our NGS (Next-Generation Sequencing) genetic testing method allows for the analysis of multiple genes simultaneously, making it possible to detect genetic variations or mutations related to CLN7.
To perform the NGS genetic test for CLN7, we require a DNA sample, which is usually obtained through a blood sample. The DNA is then sequenced using next-generation sequencing technology to analyze the MFSD8 gene for any mutations or variations.
Test Components and Price
- Test Name: MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
Sample Condition
We accept blood samples or extracted DNA for this test. Alternatively, one drop of blood can be collected on an FTA Card.
Report Delivery
You can expect to receive your test results within 3 to 4 weeks.
Test Type
This test falls under the category of metabolic disorders.
Doctor and Test Department
The MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 Genetic Test is conducted by our team of General Physicians in the Genetics department.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient who is undergoing the MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 7.
Conclusion
The results of the NGS genetic test can help confirm a diagnosis of CLN7, provide information about the specific genetic mutation present in the individual, determine the prognosis of the disease, guide treatment decisions, and offer genetic counseling to affected individuals and their families.
Test Name | MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MFSD8 Gene Ceroid lipofuscinosis neuronal type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 7 |
Test Details |
The MFSD8 gene is associated with ceroid lipofuscinosis neuronal type 7 (CLN7), which is a rare neurodegenerative disorder characterized by the accumulation of lipopigments in various tissues of the body, including the brain. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations or mutations that may be associated with a particular disorder. In the case of CLN7, NGS genetic testing can be used to identify mutations in the MFSD8 gene that may be causing the disease. The NGS genetic test for CLN7 involves obtaining a DNA sample, usually through a blood sample, from the individual suspected of having the disorder. The DNA is then sequenced using next-generation sequencing technology to analyze the MFSD8 gene for any mutations or variations. The results of the NGS genetic test can help confirm a diagnosis of CLN7 and provide information about the specific genetic mutation present in the individual. This information can be useful for determining the prognosis of the disease, guiding treatment decisions, and providing genetic counseling to affected individuals and their families. |